280 likes | 477 Views
. 47 YR old female ptCRF for the last 4 yrs on regular HDNo DM , HTN NO previous heart disease. . C/O ; fever for the last 3 w. chills
E N D
1. CASE PRESENTATION
2. 47 YR old female pt
CRF for the last 4 yrs on regular HD
No DM , HTN
NO previous heart disease
3. C/O ; fever for the last 3 w.
chills & rigors
poor appetite , wt loss , fatigue
upper abdominal pain
lt ankle pain & swelling
4. ROS ; no cough , no sputum , no chest ...pain
no vomiting , no diarrhea
no urinary symp.
no skin rash
5. PMH ; cholecystictomy
Drug H. ; oscal , neurobion , lanzoprazol motilium
6. PE BP 110/70 , PR 100 bpm , Tem 38
H&N ; pale , no LN enlargement
Chest ; clear
Heart ; reg. s1 s2 , ESM & EDM at LSB , LSM at apex
Abd. ; LUQ tenderness
Extrem. ; lt ankle swelling , no skin leasions
7. CXR ; slight cardiomegally
EKG ; s.tachycardia
Lab ; Hb 9.3 , WBC 12.9 , PLT 341
CR 5.6 , Na 129 , K 4.0 , RBS 135
CRP 341 ,ESR 120
LFT ; normal
urine ; +1 protein , +2 blood , 10-12 WBC , 20-24 RBC
8. U/S abd. ; normal
TTE ; +2 MR , +2 AI , mild AS with PG 25
EF 65 % , NO vegitations
TEE ; vegitation over the rt coronary cusp of the AV
Blood C&S ; enterococcus sensitive to ampicillin & vancomycine
9. Rx ; ampicillin 2 gm I.V BID & gentamicin 120 mg after each dialysis
10. Next day ; she developed p.edemaintubated & put on mechanical ventilator for ~ 24 hr.
After extubation , she continued to c/o abdominal pain & LUQ tenderness .
CT abdomen , large hypodense splenic lesion .
She is planned for splenectomy today.
11. Infective Endocarditis Vegetation is the characteristic lesion ( a mass of plt & fibrin in which abundant microorganisms & inflammatory cells are engorged )
Valves are most commonly involved , however , infection may occur at sites of septal defect, on chordae tendineae , mural endocardium ,PDA , coarctation of aorta
12. DIAGNOSIS BUGS + ECHO + CLINICAL = IE
Duke criteria ;
2 major ( or )
5 minors ( or )
1 major + 3 minors
13. Major criteria ;
1) Echo ; new vegetation , new valve regurg. , abscess , new partial dehiscence of prosthetic valve
2) Bugs ; positive blood culture ( X 2) for typical organisms viridans , bovis , s.aureus , enterococcus , HACEK
14. Minor criteria ;
1) predisposing heart condition or IV drug user
2) fever > 38
3) embolic phenomena
4) immunological phenomena
5) lesser echo or clinical data
15. Embolic phenomena ;
1) major arterial emboli
2) septic pulmonary or splenic emboli
3) mycotic aneurism ( cerebral )
4) janeway lesions (small nontender macular lesions on the palms & soles )
5) subungual ( splinter ) hemorrhages
16. Immunological phenomena ;
1) GN
2) arthritis
3) oslers nodes ( painful nodular lesions in the pulp of the digits )
4) roths spots ( retinal hemorrhage )
5) RF
17. Mortality 4-16 % viridans strep
15-25 % enterococcus
25- 47 % s.aureus
50 % p.auroginosa & enterobacteriaceae
18. BLOOD CULTURE 3 blood cultures in 1st 24 hr
If bacteremia is present positive blood culture in 90 % after 2 sets
HACEK 4 w to grow
Serology for Q fever , brucella ,legionella
19. Culture negative endocarditis ;
< 5 % of cases of IE
recent antibiotics
fastidious bugs ( HACEK )
fungal endocarditis
intracellular parasite ( chlamydia , brucella )
20. Strep viridans pen./ceftriaxone/vanco + gentamicin
Enterococci ampicillin + gentamicin
S.aureus vanco + genta
21. Rule of surgery Definite indication ;
1) acute valvular dysfunction with hemodynamic instability
2) intractable CHF
3) persistent infection ( antibiotic-resistant
4) myocardial invasion
22. Other indications ;
1) recurrent endocarditis
2) recurrent embolization
3) abscess formation
4) fungal endocarditis
5) prosthetic valve endocarditis
23. Splenic abscess 5 % of pts with IE
Most commonly with s.aureus , strep , gram negatives
U/S & CT cannot discriminate between abscess & infarct
Percutaneous needle aspiration confirm dx
Rx; percut. drainage , if unsuccessful or multiple abscesses splenictomy
It should be treated before valve replacement to avoid recurrence of the infection in the prosthetic valve
24. Prophylaxis for endocarditis Cardiac lesion + risk of bacteremia
Cardiac lesions ;
high risk ;
1) prosthetic valves (mechan./biopros.)
2) previous IE
3) complex cyanotic CHD
4) surgical systemic- pulmonary shunt
25. Intermediate risk lesions ;
1)HCM
2) non-cyanotic CHD
3) VHD
4) ASD
5) MVP + regurgitation or valve thickening
26. Negligible risk condition ;
1) secundum ASD
2) beyond 6 months of VSD or PDA repair
3) MVP without regurg. or valve thickening
4) CABG
5) ICD / PM
27. Procedures requiring IE prophylaxis Almost all dental procedures
Esophageal dilatation
Sclerotherapy of esophageal varices
ERCP
Rigid bronchoscopy
Prostate or bladder surgery
Cystoscopy , urethral dilatation
Tonsillectomy / adenoidectomy
GB surgery
28. Optional prophylaxis High risk pts ( prosthetic valve , previous IE,)
1) endoscopy
2) TEE
3) Delivery ( vaginal or C/S )
29. Prosthetic valve endocarditis 10 % of prosthetic valves will develop endocarditis
Mechanical = bioprosthesis
Mitral = aortic
Early < 60 days s.epidermidis
Late > 60 daysusual bacteria